Glycogen synthase kinase 3: An emerging therapeutic target

Trends in Molecular Medicine

Volumn 8, Issue 3, 2002, Pages 126-132

  Eldar Finkelman, Hagit ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; DRUG RESEARCH; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; MANIC DEPRESSIVE PSYCHOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; REGULATORY MECHANISM; REVIEW;

ALZHEIMER DISEASE; ANIMALS; BIPOLAR DISORDER; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASES; HUMANS; INSULIN RESISTANCE; SUBSTRATE SPECIFICITY;

EID: 0036090823     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(01)02266-3     Document Type: Review

References (61)

1. The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
2. Judging a protein more than its name: GSK-3
3. GSK-3 takes centre stage more than 20 years after its discovery
4. Mitogen-activated protein kinase activation is not sufficient for stimulation of glucose transport or glycogen synthase in 3T3-L1 adipocytes
5. The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle
6. The role of glucose 6-phosphate in the control of glycogen synthase
7. Wnt signaling in oncogenesis and embryogenesis - A look outside the nucleus
8. Glycogen synthase kinase-3: Functions in oncogenesis and development
9. Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity
10. Heat stress induces tyrosine phosphorylation/activation of kinase FA/GSK-3 α (a human carcinoma dedifferentiation modulator) in A431 cells
11. Okadaic acid a serine/threonine phosphatase inhibitor, induces tyrosine dephosphorylation/inactivation of protein kinase FA/GSK-3 α in A431 cells
12. Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase-3 β-dependent pathway
13. Regulation and localization of tyrosine 216 phosphorylation of glycogen synthase kinase-3β in cellular and animal models of neuronal degeneration
14. Glycogen synthase kinase 3β is tyrosine phosphorylated by PYK2
15. The novel tyrosine kinase ZAK1 activates GSK3 to direct cell fate specification
16. Structure of GSK3β reveals a primed phosphorylation mechanism
17. Crystal structure of glycogen synthase kinase 3β: Structural basis for phosphate-primed substrate specificity and autoinhibition
18. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation
19. Phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 impairs insulin action
20. In vivo regulation of muscle glycogen synthase and the control of glycogen synthesis
21. Glycogen synthase kinase-3 is an insulin-regulated C/EBPα kinase
22. PPAR γ and the molecular control of adipogenesis
23. Increased glycogen synthase kinase-3 activity in diabetes and obesity prone C57BL/6J mice
24. Potential role of GSK-3 in skeletal muscle insulin resistance type 2 diabetes
25. Role of IRS-1-GRB-2 complexes in insulin signaling
26. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
27. Mechanism of activation of protein kinase B by insulin and IGF-1
28. The function of GRB2 in linking the insulin receptor to Ras signaling pathways
29. Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling
30. IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α and obesity induced insulin resistance
31. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612
32. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)
33. Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function
34. Piecing together Alzheimer's
35. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localization of the kinase
36. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau
37. Phosphorylation of tau by glycogen synthase kinase 3β in intact mammalian cells influences the stability of microtubules
38. Distribution of active glycogen synthase kinase 3β (GSK-3β) in brains staged for Alzheimer disease neurofibrillary changes
39. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3 β and cyclin-dependent kinase 5, a component of TPK II
40. Decreased nuclear β-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3β conditional transgenic mice
41. Glycogen synthase kinase-3β phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice
42. Amyloid β peptide induces cytoplasmic accumulation of amyloid protein precursor via tau protein kinase I/glycogen synthase kinase-3 β in rat hippocampal neurons
43. Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau
44. Direct association of presenilin-1 with β-catenin
45. Presenilin 1 interaction in the brain with a novel member of the Armadillo family
46. Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase/Akt-mediated mechanism that reduces the activation of caspase-3
47. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway
48. Activation of glycogen synthase kinase 3 β (GSK-3β) by platelet activating factor mediates migration and cell death in cerebellar granule neurons
49. Glycogen synthase kinase-3 β facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium
50. Glycogen synthase kinase-3 β activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal
51. Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death
52. Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
53. Molecular targets of lithium action
54. Insulin-like effect of lithium ion on isolated rat adipocytes stimulation of glycogenesis beyond glucose transport
55. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signaling in intact cells
56. The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth
57. Glycogen synthase kinase-3β, β-catenin, and tau in postmortem bipolar brain
58. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription
59. In vitro GSK-3 inhibition enhances insulin-stimulated glucose transport in skeletal muscle of the Zucker diabetic rats
60. Anti-mitotic properties ofindirubin-3′-monoxime, a CDK/GSK-3 inhibitor: Induction of endoreplication following prophase arrest
61. The pathogenic L392V mutation of presenilin 1 decreases the affinity to glycogen synthase kinase-3 β